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SCIENTIFIC OPINION
Scientific Opinion on Flavouring Group Evaluation 220 Revision 3
(FGE.220Rev3): Consideration of genotoxic potential for α,β-unsaturated 
3(2H)-Furanones from subgroup 4.4 of FGE.19 1
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids (CEF)2, 3
European Food Safety Authority (EFSA), Parma, Italy
ABSTRACT
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety
Authority was requested to evaluate the genotoxic potential of 10 flavouring substances from FGE.19 subgroup
4.4, in the Flavouring Group Evaluation 220 (FGE.220). FGE.220 is subdivided into two subgroups: subgroup
4.4a containing [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175] and subgroup 4.4b containing [13.010,
13.084 and 13.085, 13.099 and 13.176]. For both subgroups the Panel concluded that the genotoxicity alert could
not be ruled out based on the data available and accordingly additional genotoxicity data were requested. In
FGE.220, Revision 1, the Panel concluded that for the substances in subgroup 4.4b there is no concern for
genotoxicity. In FGE.220, Revision 2, the Panel evaluated genotoxicity studies on two representative substances
of subgroup 4.4a: 2,5-dimethylfuran-3(2H)-one [FL-no:13.119] and 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-
no: 13.175]. Based on the submitted data the Panel concluded that 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119]
does not give rise to concern with respect to genotoxicity. For 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no:
13.175] the concern for genotoxicity could not be ruled out, therefore the Panel requested a repetition of the
submitted micronucleus study in the presence of S9-mix, or a combined in vivo micronucleus and Comet assay,
including analysis of the liver. The Flavour Industry has tested again 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-
no: 13.175] in an in vitro micronucleus assay as was requested by the Panel. This new study is evaluated in
FGE.220, Revision 3, where the Panel concluded that [FL-no: 13.175] does not give rise to concern with respect
to genotoxicity and can be evaluated using the Procedure. This is also applicable to other two substances in
subgroup 4.4a: 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-no:13.089] and 2,5-dimethyl4-ethoxyfuran-3(2H)-
one [FL-no:13.117]. Based on the available data the substances of this FGE are no longer of concern with
respect to genotoxicity and can be evaluated through the Procedure.
© European Food Safety Authority, 2015
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SUMMARY
Following a request from the European Commission, the EFSA Panel on Food Contact Materials,
Enzymes, Flavourings and Processing Aids (CEF) was asked to deliver a scientific opinion on the
implications for human health of chemically defined flavouring substances used in or on foodstuffs in
the Member States. In particular, the Panel was asked to evaluate 10 flavouring substances in
Flavouring Group Evaluation 220 (FGE.220) using the Procedure as referred to in the Commission
Regulation (EC) No 1565/2000.
Flavouring Group Evaluation 220 (FGE.220) concerned 10 substances, corresponding to subgroup 4.4
of FGE.19. The 10 substances are α,β-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 
13.085,13.089, 13.099, 13.117, 13.119, 13.157, 13.175 and 13.176]. The substances were further
subdivided into two subgroups as five [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175] of the 10
substances can only exist as α,β-unsaturated ketones (subgroup 4.4a) while in the other five substances 
[13.010,13.084 and 13.085, 13.099 and 13.176], the α,β-double bond can be involved in keto-enol 
tautomerism (subgroup 4.4b). For both groups the Panel concluded that the genotoxicity alert could
not be ruled out based on data available at that time, and accordingly additional genotoxicity data were
requested for both groups.
Revision 1 of FGE.220 (FGE.220Rev1) concerned the evaluation of additional data submitted by
Industry in response to the requested genotoxicity data in FGE.220 on the representative substance for
subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. The Panel concluded that for
the substances [13.010, 13.084 and 13.085, 13.099 and 13.176] in subgroup 4.4b there is no concern
for genotoxicity, and these substances were accordingly evaluated through the Procedure in FGE.99.
In FGE.220, Revision 2, genotoxicity data related to subgroup 4.4a were evaluated. The Flavour
Industry informed that one of the representative substances, 5-methylfuran-3(2H)-one [FL-no:
13.157], is not in common use in the Flavour Industry and is no longer supported. As an alternative
substance for testing within this subgroup, the Flavour Industry had proposed the structurally related
substance 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119]. Accordingly, additional genotoxicity data
were submitted for 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119] and 4-acetyl-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.175]. These data were examined by the Panel which concluded that 2,5-
dimethylfuran-3(2H)-one [FLno:13.119] does not give rise to concern with respect to genotoxicity and
can accordingly be evaluated using the Procedure. For 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no:
13.175] the concern for genotoxicity could not be ruled out and therefore the Panel requested a
repetition of the micronucleus study in the presence of S9-mix, applying the same conditions and
possibly in addition modified conditions, or a combined in vivo micronucleus and Comet assay,
including analysis of liver.
The Industry has tested again 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] in an in vitro
micronucleus assay in the presence of S9-mix (3+21 hours). These data are evaluated in the present
Revision 3 of FGE.220 (FGE.220 Rev3). The available data suggest that 4-acetyl-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.175] did not induce reproducible statistically significant increase in
micronucleated binucleate cells across replicate cultures indicating that the test substance can be
considered negative for clastogenicity and aneugenicity. The Panel therefore concluded that [FL-no:
13.175] does not give rise to concern with respect to genotoxicity and accordingly can be evaluated
using the Procedure. This is also applicable to 2,5-dimethyl-4-methoxyfuran-3(2H)-one [FL-
no:13.089] and 2,5-dimethyl4-ethoxyfuran-3(2H)-one [FL-no:13.117] which are covered by the
representative substance 4-acetyl2,5-dimethylfuran-3(2H)-one [FL-no:13.175].
Based on the available data all 9 substances of this FGE are no longer of concern with respect to
genotoxicity and can be evaluated through the Procedure.
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION
The use of flavouring is regulated under Regulation (EC) No 1334/20084 of the European Parliament
and Council of 16 December 2008 on flavourings and certain food ingredients with flavouring
properties for use in and on foods. On the basis of Article 9(a) of this Regulation an evaluation and
approval are required for flavouring substances.
The Union List of flavourings and source materials was established by Commission Implementing
Regulation (EC) No 872/20125. The list contains flavouring substances for which the scientific
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/20006.
On 25 September 2013, the EFSA Panel on Food Contact Materials, Enzymes, Flavourings and
Processing Aids adopted an opinion on Flavouring Group Evaluation 220 (FGE.220Rev2):
Consideration of genotoxicity data on representatives for heterocyclic α,β-unsaturated Aldehydes, 
Ketones and Related Substances with the α,β-conjugation in the Ring or in the side chain. 
On the basis of the data supplied, the Opinion concluded that the concern for genotoxicity could not be
ruled out for the substances in this subgroup and therefore the Panel request a repetition of
micronucleus study in the presence of S9-mix applying the same conditions and possible in addition
modified conditions, or by a combined in vivo micronucleus study and Comet assay, including
analysis of the liver.
The applicant has submitted additional data in response to this EFSA evaluation.
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION
The European Commission requests the European Food Safety Authority (EFSA) to evaluate this new
information and, depending on the outcome, proceed to the full evaluation on these flavouring
substances in accordance with Commission Regulation (EC) No 1565/2000.
4 Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and
certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No
1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. OJ L 354, 31.12.2008, p.34–50.
5 Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances
provided for by Regulation (EC) No 2232/96 of the European Parliament and of the Council, introducing it in Annex I to
Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC)
No 1565/2000 and Commission Decision 1999/217/EC. OJ L 267, 2.10.2012, p. 1–161.
6 Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an
evaluation programme in application of Regulation (EC) No 2232/96. OJ L 180, 19.7.2000, p. 8–16.
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METHODOLOGIES AND DATA
Methodologies
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register
being α,β-unsaturated aldehydes or ketones and precursors which could give rise to such carbonyl 
substances via hydrolysis and / or oxidation (EFSA, 2008a).
The α,β-unsaturated aldehyde and ketone structures are structural alerts for genotoxicity (EFSA, 
2008a). The Panel noted that there were limited genotoxicity data on these flavouring substances but
that positive genotoxicity studies were identified for some substances in the group.
The α,β-unsaturated carbonyls were subdivided into subgroups on the basis of structural similarity 
(EFSA, 2008a). In an attempt to decide which of the substances could go through the Procedure, a
(quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of these substances
was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-MultiCASE
Models and ISS-Local Models, (Gry et al., 2007)).
The Panel noted that for most of these models internal and external validation has been performed, but
considered that the outcome of these validations was not always extensive enough to appreciate the
validity of the predictions of these models for these alpha, beta- unsaturated carbonyls. Therefore, the
Panel considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and
decided not to take substances through the procedure based on negative (Q)SAR predictions only.
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni and Netzeva,
2007a; Benigni and Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007;
Nikolov et al., 2007) and the fact that there are available data on genotoxicity, in vitro and in vivo, as
well as data on carcinogenicity for several substances. Based on these data the Panel decided that 15
subgroups (1.1.1, 1.2.1, 1.2.2, 1.2.3, 2.1, 2.2, 2.3, 2.5, 3.2, 4.3, 4.5, 4.6, 5.1, 5.2 and 5.3) (EFSA,
2008a) could not be evaluated through the Procedure due to concern with respect to genotoxicity.
Corresponding to these subgroups, 15 Flavouring Group Evaluations (FGEs) were established:
FGE.200, 204, 205, 206, 207, 208, 209, 211, 215, 219, 221, 222, 223, 224 and 225.
For 11 subgroups the Panel decided, based on the available genotoxicity data and (Q)SAR predictions,
that a further scrutiny of the data should take place before requesting additional data from the
Flavouring Industry on genotoxicity. These subgroups were evaluated in FGE.201, 202, 203, 210, 212,
213, 214, 216, 217, 218 and 220. For the substances in FGE.202, 214 and 218 it was concluded that a
genotoxic potential could be ruled out and accordingly these substances will be evaluated using the
Procedure. For all or some of the substances in the remaining FGEs, FGE.201, 203, 210, 212, 213,
216, 217 and 220 the genotoxic potential could not be ruled out.
To ease the data retrieval of the large number of structurally related α,β-unsaturated substances in the 
different subgroups for which additional data are requested, EFSA worked out a list of representative
substances for each subgroup (EFSA, 2008c). Likewise an EFSA genotoxicity expert group has
worked out a test strategy to be followed in the data retrieval for these substances (EFSA, 2008b).
The Flavouring Industry has been requested to submit additional genotoxicity data according to the list
of representative substances and test strategy for each subgroup.
Data
The Flavouring industry has now submitted additional data and the present FGE concerns the
evaluation of these data requested on genotoxicity.
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EFSA Journal 2015;13(5):4117 7
ASSESSMENT
1. History of the Evaluation of the Substances in Subgroup 4.4
Subgroup 4.4 of FGE.19 consists of ten α,β-unsaturated 3(2H)-furanones, which have been further 
subdivided into two groups 4.4a and 4.4b based on chemical structures (Table 2). For both groups the
Panel concluded that the genotoxicity alert could not be ruled out based on data available at that time,
and accordingly additional genotoxicity data were requested for both groups. The additional
information should be based on specific data requested in FGE.220 and performed on representative
substances selected from both groups (EFSA, 2008c).
In the EFSA Opinion “List of α,β-unsaturated aldehydes and ketones representative of FGE.19 
substances for genotoxicity testing” (EFSA, 2008c), representative flavouring substances have been
selected for subgroups 4.4a and 4.4b, corresponding to FGE.220, for which additional data on
genotoxicity were requested, according to the Opinion of the Panel on the Genotoxicity Test Strategy
for Substances Belonging to Subgroups of FGE.19” (EFSA, 2008b).
Revision 1 of FGE.220 (FGE.220Rev1), concerns the evaluation of additional data submitted by
Industry in response to the requested genotoxicity data in FGE.220 on the representative substance for
subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. These new data are
described and evaluated in Section 4 in the present version of FGE.220.
Revision 2 of FGE.220 (FGE.220Rev2), concerns the evaluation of additional data submitted by
Industry in response to requested genotoxicity data in FGE.220 on representative substances for
subgroup 4.4a (see Table 1). The Flavour Industry has informed that one of the representative
substances, 5-methylfuran-3(2H)-one [FL-no: 13.157], is not in common use in the flavour industry
and is no longer supported. As an alternative substance for testing within this subgroup, the Flavour
Industry had proposed the structurally related substance of subgroup 4.4a, 2,5-dimethylfuran-3(2H)-
one [FL-no: 13.119] and submitted data on this substance and on 4-acetyl-2,5-dimethylfuran-3(2H)-
one [FL-no: 13.175] (Table 1).
FGE Adopted by EFSA Link No. of
Substances
FGE.220 29 January 2009 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902503180.htm
10
FGE.220Rev1 30 September 2010 http://www.efsa.europa.eu/en/efsajournal/pub/1841.htm 10
FGE.220Rev2 25 September 2013 http://www.efsa.europa.eu/en/efsajournal/pub/3390.htm 9
FGE.220Rev3 7 May 2015 http://www.efsa.europa.eu/en/efsajournal/pub/4117.htm 9
The present revision of FGE.220 concerns the evaluation of new data received for 4-acetyl-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.175] (Lloyd, 2014). The new information supplied by the
Industry is a repetition of the short-term treatment, (3+ 21hours) in the presence of S9 metabolism, of
a micronucleus study earlier submitted and which showed equivocal results in the short-term treatment
(3+21 hours) in the presence of S9-mix (Lloyd, 2012).
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Table 1: Representative substances selected for FGE.19 Subgroup 4.4 (FGE.220)
Representative substances selected by EFSA for FGE.19 Subgroup 4.4 (FGE.220) (EFSA, 2008c)
Subgroup FL-no Register name for representatives Structural formula
4.4a 13.157 5-Methylfuran-3(2H)-one
Not supported any longer by EFFA
O
O
13.119 2,5-Dimethylfuran-3(2H)-one
New representative substance suggested by EFFA
O
O
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
4.4b 13.010 4-hydroxy-2,5-dimethylfuran-3(2H)-one O
OHO
In Section 6, the evaluation of the new genotoxicity data received for 4-acetyl-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.175] is described.
Sections 2 - 5 report the same information that was presented in the earlier versions of FGE.220.
2. Presentation of the Substances in Flavouring Group Evaluation 220
The present Flavouring Group Evaluation 220 (FGE.220) concerns nine substances, which are
presented in Table 2. The nine substances correspond to subgroup 4.4 of FGE.19 (EFSA, 2008a).
These substances are all α,β-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 13.085, 13.089, 
13.099, 13.117, 13.119, 13.175 and 13.176]. Four of the nine substances can only exist as ketones
[FL-no: 13.089, 13.117, 13.119 and 13.175] (subgroup 4.4a). In the remaining five substances, the
α,β-double bond can be involved in keto-enol tautomerism as such [FL-no: 13.010, 13.084 and 
13.085] or after hydrolysis of the ester moiety [13.099 and 13.176] (subgroup 4.4b).
A summary of their current evaluation status of both subgroups 4.4a and 4.4b by the JECFA is given
in Appendix A, Table 3 (JECFA, 2006).
The α,β-unsaturated aldehyde and ketone structures are considered by the Panel to be structural alerts 
for genotoxicity (EFSA, 2008a). Accordingly, the available data on genotoxic or carcinogenic activity
for the ten ketones in FGE.220 were considered.
The Panel has also taken into consideration the outcome of the predictions from five selected (Q)SAR
models (Benigni & Netzeva, 2007a; Gry et al., 2007; Nikolov et al., 2007) on the ketones in the
present FGE. The ten α,β-unsaturated ketones and their (Q)SAR predictions are described in 
Section 3.1 and summarised in Appendix B, Table 4.
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Table 2: Specification Summary of the Substances in the Present Group Evaluation (JECFA, 2002)
FL-no
JECFA-
no
EU Register name Structural formula FEMA no
CoE no
CAS no
Phys.form
Mol. formula
Mol. weight
Solubility (a)
Solubility in
ethanol (b)
Boiling point, °C (c)
Melting point, °C
ID test
Assay minimum
Refrac. Index (d)
Spec. gravity (e)
Substances in subgroup 4.4a (Furan-3(2H)-ones)
13.089
1451
2,5-Dimethyl-4-methoxyfuran-3(2H)-
one
O
O O
3664
4077-47-8
Liquid
C7H10O3
142.15
Insoluble
Soluble
61-63 (0.4 hPa)
-
NMR
97 %
1.475-1.481
1.091-1.097
13.117 2,5-Dimethyl-4-ethoxyfuran-3(2H)-one O
O O 65330-49-6
Solid
C8H12O3
156.18
Freely soluble
251
60
-
95 %
n.a.
n.a.
13.119 2,5-Dimethylfuran-3(2H)-one O
O
11066
14400-67-0
Liquid
C6H8O2
112.13
Practically insoluble
Freely soluble
68 (16 hPa)
-
IR NMR MS
95 %
1.473-1.479
1.050-1.060
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
Solid
C8H10O3
154.17
Freely soluble
283
34
-
95 %
n.a.
n.a.
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism)
13.010
1446
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one
O
OHO
3174
536
3658-77-3
Solid
C6H8O3
128.13
Insoluble
Soluble
n.a.
78-80
IR NMR MS
98 %
n.a.
n.a.
13.084
1449
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone
O
OHO
3623
27538-09-6
Liquid
C7H10O3
142.15
Soluble
Soluble
103 (20 hPa)
-
IR NMR
96 %
1.509-1.514
1.133-1.143
13.085
1450
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
3635
11785
19322-27-1
Solid
C5H6O3
114.10
Soluble
Soluble
n.a.
126-133
NMR
97 %
n.a.
n.a.
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Table 2: Specification Summary of the Substances in the Present Group Evaluation (JECFA, 2002)
FL-no
JECFA-
no
EU Register name Structural formula FEMA no
CoE no
CAS no
Phys.form
Mol. formula
Mol. weight
Solubility (a)
Solubility in
ethanol (b)
Boiling point, °C (c)
Melting point, °C
ID test
Assay minimum
Refrac. Index (d)
Spec. gravity (e)
13.099
1456
4-Acetoxy-2,5-dimethylfuran-3(2H)-
one
O
OO
O 3797
4166-20-5
Liquid
C8H10O4
170.17
Slightly soluble
Soluble
243
-
IR NMR MS
95 %
1.476-1.480
1.159-1.167
13.176
1519
Furaneyl butyrate O
OO
O 3970 Liquid
C10H14O4
198.22
Insoluble
Soluble
287
-
NMR
95 %
1.467-1.473
1.095-1.103
(a): Solubility in water, if not otherwise stated.
(b): Solubility in 95 % ethanol, if not otherwise stated.
(c): At 1013.25 hPa, if not otherwise stated.
(d): At 20°C, if not otherwise stated.
(e): At 25°C, if not otherwise stated.
n.a: not applicable.
Flavouring Group Evaluation 220 Revision 3
EFSA Journal 2015;13(5):4117 11
3. Data available to and Evaluated by the Panel in FGE.2207
3.1. (Q)SAR Predictions
In Appendix B, Table 4, the outcomes of the (Q)SAR predictions for possible genotoxic activity in
five in vitro (Q)SAR models (ISS Local Model-Ames test, DTU-NFI MultiCASE-Ames test, -
Chromosomal aberration test in Chinese hamster ovary cells (CHO), -Chromosomal aberration test in
Chinese hamster lung cells (CHL), and -Mouse lymphoma test) are presented.
For none of the candidate substances in this FGE a prediction was obtained with the ISS Local Model
for gene mutations in Salmonella TA100, as all substances were out of domain. The DTU-NFI
MultiCase models for mutagenicity predicted negative (no genotoxic potential) in the Ames test for all
10 substances, and also for three substances (all three in subgroup 4.4b) in the Mouse lymphoma
assay. For one substance [FL-no: 13.157] from subgroup 4.4a, a positive response in the Mouse
lymphoma assay was predicted. The other candidate substances were out of domain. All but four
substances from the subgroup were out of domain for both the Chromosomal aberration CHO and
CHL models. The four substances from subgroup 4.4b were in the domain of the Chromosomal
aberrations CHL model and for these four the application of the model resulted in a negative
prediction.
It is concluded that these models, except for the negative predictions for the substance in the DTU-NFI
MultiCASE model for Ames test, do not seem to generate a reliable and reproducible pattern of
predictions for this group. Negative predictions in mammalian cells were only available for four of the
substances in subgroup 4.4b (furan-3(2H)-ones in which the α,β- double bond can be involved in keto-
enol tautomerism). One positive prediction was available for genotoxic activity in mammalian cells for
a substance in subgroup 4.4a (furan-3(2H)-ones).
3.2. Carcinogenicity Studies
A carcinogenicity study with chronic exposure is available for one substance in subgroup 4.4b.
In an OECD Guideline 451 and GLP compliant study, groups of 60 male and 60 female Sprague-
Dawley rats were fed diets containing 0 (controls), 100, 200 or 400 mg 4-hydroxy-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.010] /kg body weight (bw) per day for two years. Mean body weights and body
weight gains of male and female rats exposed to 400 mg 4-hydroxy-2,5-dimethyl-3(2H)-furanone/kg
bw per day were decreased compared to those of the controls in the last part of the study. No
neoplasms or non-neoplastic lesions were attributed to exposure to 4-hydroxy-5-dimethyl-3(2H)-
furanone. The NOAEL was 200 mg/kg bw per day (Kelly and Bolte, 2003).
The Panel concluded that the study on 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] was
valid and did not show a carcinogenic potential in rats.
Study validation and results are presented in Appendix C, Table 5.
3.3. Genotoxicity Studies
Genotoxicity studies are available for four of the candidate substances in FGE.220, as summarised in
Appendix C, Tables 6 and 7.
Subgroup 4.4a (Furan-3(2H)-ones)
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]) no mutagenic
activity was observed in S. typhimurium in a valid assay. No experimental data were available for any
of the other substances in this subgroup.
7 The data presented in Section 3 are cited from the first version of the present FGE.220. These data are the basis of the
conclusions in FGE.220 requesting additional genotoxicity data.
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Subgroup 4.4b (Furan-3(2H)-ones in which the α,β- double bond can be involved in keto-enol 
tautomerism).
For the three remaining substances with available genotoxicity data, which belong to subgroup 4.4b
the following results have been reported.
4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]
For 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] publications on in vitro and in vivo
studies are available. In three studies the potential of the test substance to induce gene mutations in S.
typhimurium was studied. The substance was found positive in two valid studies (Gilroy et al, 1978;
Hiramoto et al, 1996b) and in one study with limited validity (Xing et al, 1988). The substance did not
cause gene mutations in a valid study in Escherichia coli WP2 uvrA- (Gilroy et al, 1978). It was also
observed that the substance caused DNA repair in a less relevant bacterial test (Xing et al, 1988) and
single strand breaks in purified DNA (Hiramoto et al, 1996b).
All in vivo studies provided indications for a genotoxic potential. Two studies showing micronucleus
formation in peripheral blood cells were considered valid (Hiramoto et al., 1996b; Hiramoto et al.,
1998); in a third study similar evidence but of limited validity was obtained (Xing et al., 1988). The
latter authors also reported an increase in sister chromatid exchanges (SCE) in mouse bone marrow,
but the validity of that observation could not be assessed. In addition this endpoint is of questionable
relevance for the assessment of genotoxicity.
In addition to the genotoxicity observed in somatic cells, three studies provided evidence for
genotoxicity in germ cells.
The evidence of chromosome aberration induction in mouse germ cells provided in the study by Xing
et al. (1988) is poor because it is essentially based on an increase of premature disjunction of sex
chromosomes and autosomes at metaphase I. This effect could be considered at most an alert of
possible subsequent missegregation events; even so, data have been published (Liang and Pacchierotti,
1988) showing the lack of correlation between univalents at metaphase I and aneuploidy at
metaphase II.
Tian et al. (1992) reported an induction of SCE in spermatogonia. Incomplete information is given on
the experimental protocol. There is a dose-dependent increase of SCE/cell, with each dose group
significantly higher than the negative control. For these reasons, these data seem to be convincing
although obtained on a small number (3) of animals/group. The relevance of SCE in spermatogonia as
an indicator of heritable genetic damage is limited.
In the same paper Tian et al. (Tian et al., 1992) reported the induction of micronuclei in early sperm
cells. This test measures the induction of DNA lesions in preleptotene spermatocytes that can lead to
breaks and fragments several days later, at the first or second meiotic division. The test has not been
standardised and validated for routine regulatory application, but has been conducted by more than
one laboratory in the world with consistent results. The study seems adequately performed. Staining
with Giemsa is not optimal and does not allow to distinguish among phases of spermatid
differentiation as recommended by the guidelines (Russo, 2000). However, this drawback could hardly
produce an overestimation of the effect, more likely, if any, an underestimation.
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] and 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [FL-no: 13.084]
Reverse mutations were also observed in S. typhimurium TA100, but not TA98 with 4-hydroxy-5-
methylfuran-3(2H)-one [FL-no: 13.085] (Hiramoto et al, 1996a) and with 2-ethyl-4-hydroxy-5-
methyl-3(2H)-furanone [FL-no: 13.084] (Li et al, 1998). The other strains were not tested. The same
substances could induce single strand breaks in purified DNA (Hiramoto et al, 1996a; Li et al, 1998).
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With 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] also induction of micronuclei in
peripheral erythrocytes was observed in two valid in vivo assays (Hiramoto et al, 1998; Li et al, 1998).
Mechanistic data
For the substances in subgroup 4.4b also mechanistic studies were carried out with [FL-no: 13.010,
13.084 and 13.085], all of which were considered valid. These substances were identified as Maillard
reaction products in soy sauce. When the substance [FL-no: 13.085] was incubated with supercoiled
pBR 322 plasmid DNA, single strand breaks were observed at pH 4.4, but not at pH 7.4. When a spin
trap was also present, formation of hydroxy radicals together with a carbon-centered radical could be
demonstrated. Subsequent addition of superoxide dismutase and catalase inhibited the DNA breaking
showing involvement of hydrogen peroxide. Potassium iodide, mannitol, sodium azide and ethanol
were also inhibitory to the DNA breaking showing involvement of hydroxy radicals. Spin trapping
agents and thiol compounds and metal chelators also effectively inhibited the breaking of DNA
(Hiramoto et al., 1996a). Similar studies (Hiramoto et al., 1996b; Li et al., 1998) were carried out with
[FL-no: 13.010 and 13.084] with the same results and it was also demonstrated that these substances
are capable to reduce Fe3+ at neutral or alkaline pH (Li et al., 1998).
Study results and comments on study validity are presented in Appendix C, Tables 6 and 7.
3.4. Conclusion on Genotoxicity and Carcinogenicity in FGE.220
Apart from the negative predictions for the substances in the DTU-NFI MultiCASE model for the
Ames test, the (Q)SAR models do not seem to generate a reliable and reproducible pattern of
predictions on the genotoxicity for the substances in this FGE.
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]) no mutagenic
activity was observed in S. typhimurium in a valid assay. This study result is insufficient to reach a
conclusion as to the absence of genotoxicity for this subgroup.
With several substances in subgroup 4.4b indications have been obtained in in vitro studies that the
genetic damage they cause is related to the generation of reactive oxygen species as a result of redox
cycling in combination with metal ions present in the media. The valid positive in vivo data were
obtained with high dose levels that may be anticipated to have exhausted the anti-oxidant capacity of
the target cells. This, in combination with the absence of carcinogenicity observed in a valid
carcinogenicity study in rats with one of the substances [FL-no: 13.010], which was tested positive in
the genotoxicity assays, takes away a concern for genotoxic events resulting in carcinogenicity in
somatic cells.
For two of the studies in which genotoxic effects were observed in germ cells in vivo the studies had
limited validity and/or address endpoints that may have limited relevance for the assessment of
genotoxic potential. The Panel noted that a positive result was obtained in a micronucleus study in
early sperm cells. However, a micronucleus test does not discriminate between aneuploidy and
chromosomal breakage. The observed effects in the germ cells could be the result of the
malsegregation of chromosomes which is generally considered a thresholded event. They may
alternatively be the result of the (thresholded) generation of reactive oxygen species.
3.5. Conclusions in FGE.220
For the substances in subgroup 4.4a [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175], the Panel
considered that presently the available data on genotoxicity are too limited to evaluate these
substances through the Procedure. Additional studies are needed as outlined in the Genotoxicity Test
Strategy for Substances belonging to Subgroups of FGE.19 (EFSA, 2008b).
For the substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], evidence for
genotoxicity was obtained in vitro and in vivo. Evidence is available from in vitro studies that the
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genotoxicity of the candidate substances in this subgroup may be caused by indirect (thresholded)
mechanisms of action (in particular generation of reactive oxygen species). The concern for
carcinogenicity is alleviated, since one of the substances, for which positive genotoxicity data in mice
were obtained, was not carcinogenic in a valid chronic assay in rats. Therefore, no further genotoxicity
tests in somatic cells are required. However, some evidence was also available that this substance
might elicit genotoxic effects in germ cells, which theoretically may result in reduced reproductive
capacity or in inheritable genetic damage. Reduced reproductive capacity and inheritable genetic
damage are toxicological endpoints which differ from carcinogenicity and therefore, the negative
results for the carcinogenicity study cannot be used to overrule this concern. Also it is not clear if (and
if so to what extent) the thresholded mechanism mentioned above would be relevant for genotoxic
effects in the germ cells. Therefore, the Panel concluded that presently these five substances cannot be
evaluated through the Procedure.
The Panel recognised that the studies which provided indications for germ cell genotoxicity are of
limited validity. For that reason a robust GLP-controlled cytogenetic investigation in mouse
spermatocytes according to the OECD Guideline 483 is requested.
4. Additional Genotoxicity Data Evaluated by the Panel in FGE.220Rev18
4.1. Evaluation of Additional Data for Subgroup 4.4b
In response to the EFSA request in FGE.220, of a cytogenetic study in mouse spermatocytes (OECD
TG 483), Industry has submitted the following data:
• 2-year carcinogenicity bioassay in rats with a substance coded ST 07 C99 (this is the study on
[FL-no: 13.010] by Kelly & Bolte, 2003);
• oral male fertility study of FURANEOL = 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no:
13.010] (test article code ST17C07) in rats (Sloter, 2008);
• oral micronucleus assay in bone marrow cells of the mouse with neofuraneol (no identification of
this substance is available) (Honarvar, 2008);
• mouse lymphoma (TK) specific locus mutation assay with compound 0478/1 (Ross & Harris,
1979a).
The Panel noted that among the studies submitted by Industry only the rat fertility study, which
includes also the analysis of dominant lethals, is considered relevant for the specific EFSA request.
The 2-year carcinogenicity bioassay in rats by Kelly and Bolte (Kelly and Bolte, 2003) was already
evaluated by the Panel in the previous version of this FGE (Section 3.2 and Table 5). It was considered
as a valid, negative study, however not relevant for the evaluation of possibly inheritable damage.
Also the mouse bone marrow micronucleus assay with neofuraneol (Honarvar, 2008) and the in vitro
mouse lymphoma TK assay (Ross and Harris, 1979) are considered not relevant to clear the concern
for possible inheritable damage. Furthermore, an adequate identification of the test substance
neofuraneol was not possible, due to incomplete reporting. For these reasons these three studies will
not be further considered in this section.
Oral Male Fertility Study of 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] in Rats (Sloter,
2008)
The objective of this study, performed according to ICH Guideline 4.1.1 (ICH, 1996) under GLP, was
to determine the potential effects of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] on
8 The data presented in Section 4 are cited from the revision 1 of FGE.220 (FGE.220Rev1). These data are the basis of the
conclusions in FGE.220Rev1 requesting additional genotoxicity data.
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mating, fertility and gonadal function in male rats with two separate mating trials. 4-Hydroxy-2,5-
dimethylfuran-3(2H)-one was administered by gavage once daily to three groups of 25 male
Crl:CD(SD) rats. Dosage levels were 100, 500 and 1000 mg/kg bw/day. A concurrent control group of
25 males received the vehicle (propylene glycol) on a comparable regimen. The first mating (Phase I),
following 2 weeks of male administration, using untreated females, was conducted to detect potential
elicitation of early genotoxic effects on the embryo with reduced risk of test-article related deficiencies
in mating or fertility. The second mating (Phase II), following 9 weeks of male dose administration,
was conducted following male exposure throughout a complete spermatogenic cycle using a second
set of untreated females.
There was no test-article related mortality noted in this study. A slightly lower mean body-weight gain
was noted in the 1000 mg/kg/day group when evaluated for the overall treatment period. No test-
article related effects on male reproductive performance were observed at 100, 500 and 1000 mg/kg
per day when males were mated with Phase I or Phase II females. In particular, there were no effects
on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production rate,
motility and morphology, reproductive organs or macroscopic findings) at any of the doses tested. The
mean percentage of sperm with abnormal morphology (separated head and flagellum) was slightly
higher in the 500 and 1000 mg/kg per day groups; however, this was primarily attributed to a single
male in the respective groups and therefore not considered test-article related. The number of females
mated and the number of pregnant females was comparable to controls. Uterine examination was
performed for both Phase I and Phase II females. The analysis of embryonic data (corpora lutea,
implantation sites, viable embryos, dead embryos, early resorptions, late resorptions, total resorptions,
post- and pre-implantation losses) did not reveal dominant lethal effects. The study does not indicate a
potential of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] to affect male fertility. This
study can be considered to be equivalent to an OECD 478 Dominant Lethal assay. The Dominant
Lethal assay has been recommended as follow-up study in case of positive results in the OECD
Guideline 483 (Eastmond et al., 2009). On this basis, the Panel considers it acceptable to substitute the
requested study according to OECD Guideline 483 with the Dominant Lethal test.
Study results and comments on study validity are presented in Appendix C, Table 8.
4.2. Conclusion on Additional Data in FGE.220Rev1
The results of a valid rat fertility and dominant lethal study have shown that 4-hydroxy-2,5-
dimethylfuran-3(2H)-one is unable to induce both adverse effects on male rat reproductive capacity
and dominant lethality. On this basis, the Panel concludes that for this substance there is no concern
for its potential to induce heritable genetic damage or adverse effects on male reproductive capacity.
Accordingly the substances in subgroup 4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and
13.176] can be evaluated using the Procedure. Since no data were submitted to further evaluate the
genotoxic potential of the substances in subgroup 4.4a, the Panel in FGE.220Rev1 maintained its
position that for this subgroup additional data on genotoxicity are needed.
5. Additional Genotoxicity Data Evaluated by the Panel in FGE.220Rev29
5.1. In vitro Genotoxicity Studies for Subgroup 4.4a
In response to the EFSA request in FGE.220 for additional genotoxicity data for subgroup 4.4a the
Flavour Industry (IOFI, 2012) has submitted in vitro genotoxicity data on:
• 2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] (Ames test and in vitro micronucleus assay)
• 4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] (Ames test and in vitro micronucleus
assay)
9 The data presented in Section 5 are cited from the revision 2 of FGE.220 (FGE.220Rev2). These data are the basis of the
conclusions in FGE.220Rev2 requesting additional genotoxicity data
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Bacterial mutation assays
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119]
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] was tested in Salmonella typhimurium strains TA98,
TA100, TA1535, TA1537 and TA102 in the absence or presence of S9-mix (Sokolowski, 2007). In
the first experiment the concentrations tested were 3, 10, 33, 100, 333, 1000, 2500 and 5000 μg/plate, 
and plate incorporation methodology was used. In the second experiment the concentrations were 33,
100, 333, 1000, 2500 and 5000 μg/plate of 2,5-dimethylfuran-3(2H)-one [FL-no: 13.119], and 
treatments in the absence and in the presence of S9-mix used the pre-incubation method. No toxic
effects, evident as a reduction in the number of revertants, occurred in the test groups with and without
metabolic activation. The solvent control data reported for strain TA102 in the absence of S9-mix,
indicated slightly increased numbers of revertant colony numbers (538 ± 28) compared to historical
controls (407.1 ± 78.3). Since the effect is small in the control, the effect is considered by the study
director to be based upon biologically irrelevant fluctuations in the number of colonies. Thus, the
study design complied with current recommendations and an acceptable top concentration was
achieved. There was no evidence of any mutagenic effect induced by 2,5-dimethylfuran-3(2H)-one
[FL-no: 13.119] in any of the strains, either in the absence or presence of S9-mix.
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175]
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] was tested in S. typhimurium strains TA98,
TA100, TA1535, TA1537 and TA102 in the absence and presence of S9-mix (Bowen, 2011). In the
first experiment the concentrations were 0.32, 1.6, 8, 40, 200, 1000 and 5000 μg/plate of 4-acetyl-2,5-
dimethylfuran-3-(2H)-one [FL-no: 13.175] and the plate incorporation methodology was used. Slight
thinning of the background lawn was observed at 5000 μg/plate for all test strains in the absence and 
presence of S9-mix. In the second experiment the concentrations were 78.13, 156.3, 312.5, 625, 1250,
2500 and 5000 μg/plate and the treatments in the presence of S9-mix used the pre-incubation method. 
No clear evidence of toxicity was observed. Thus, the study design complied with current
recommendations and an acceptable top concentration was achieved. There was no evidence of any
mutagenic effect induced by 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] in any of the
strains, either in the absence or presence of S9-mix.
Micronucleus Assays
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119]
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] was evaluated in an in vitro micronucleus assay in
human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in
the presence and absence of rat S9-mix fraction as an in vitro metabolising system. Cells were
stimulated for 48 hours with phytohaemagglutinin (PHA) to produce exponentially growing cells, and
then treated for 3 hours (followed by 21 hours recovery) with 0, 900, 1000 or 1120 μg/ml of 2,5-
dimethylfuran-3(2H)-one [FL-no: 13.119] in the absence and in the presence of S9-mix. The levels of
cytotoxicity (reduction in replication index) at the top concentrations were 12 and 2 % respectively. In
a parallel assay, cells were treated for 24 hours with 0, 900, 1000 and 1120 μg/ml of 2,5-
dimethylfuran-3(2H)-one [FL-no: 13.119] in the absence of S9-mix with no recovery period. The top
concentration induced 22 % cytotoxicity. There were 2 replicate cultures per treatment, and 1000
binucleate cells per replicate (i.e. 2000 cells per concentration) were scored for micronuclei. Thus the
study design complies with current recommendations (including draft OECD Guideline 487), and
acceptable levels of cytotoxicity were achieved at the top concentrations used in all parts of the study.
No evidence of chromosomal damage or aneuploidy was observed by increased levels of
micronucleated binucleate cells (MNBN) in the presence or absence of S9-mix metabolic activation
(Lloyd, 2011).
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4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL 13.175]
In a similar experiment, human peripheral lymphocyte cells were stimulated for 48 hours with PHA to
produce exponentially growing cells, and then treated for 3 hours (followed by 21 hours recovery)
with 0, 1000, 1250 or 1542 μg/ml of 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] in the 
absence and in the presence of S9-mix. The levels of cytotoxicity (reduction in replication index) at
the top concentrations were 20 and 7 % respectively.
In a parallel assay, cells were treated for 24 hours with 0, 400, 600, 900 and 950 μg/ml of 4-acetyl-2,5-
dimethylfuran-3(2H)-one [FL-no: 13.175] in the absence of S9-mix with no recovery period. The top
concentration induced 54 % cytotoxicity. There were two replicate cultures per treatment, and 1000
binucleate cells per replicate were scored for micronuclei. Thus the study design complies with current
recommendations (including draft OECD guideline 487), and acceptable levels of cytotoxicity were
achieved at the top concentrations used in all parts of the study.
Initially (following the scoring of 1000 binucleate cells/culture), treatment of cells for 3 hours with a
21 hour recovery period in the presence of S9-mix resulted in mean frequencies of MNBN cells
(0.55% , 0.85 % and 1.25 %, at 1000, 1250 and 1542 μg/ml, respectively) that were significantly 
higher (p ≤ 0.01) compared with those observed in concurrent controls (0.20 %) at all three 
concentrations analysed, giving 3 %, 0 % and 7 % reductions in RI, respectively. The MNBN cell
frequencies exceeded the normal range (0.1 % to 1.1 %) only in single cultures at 1250 and 1542
μg/ml (1.2 % and 1.6 %, respectively). It was noted that one of the solvent control replicates fell to 0 
%, which is outside of historical control levels and would have impacted the statistical significance.
To confirm this result additional 1000 binucleate cells were scored for the vehicle controls “C” and
“D” replicate cultures derived from new human blood cultures and an additional 1000 binucleate cells
were scored from each of the three test article concentrations analysed, derived from the same human
blood culture used in the first experiment. Following the additional scoring, the mean frequencies of
MNBN cells were significantly higher but at lower statistical level (p ≤ 0.05), compared to those 
observed in the concurrent vehicle controls at the two highest concentrations analysed (1250 and 1542
μg/ml). It was noted that only one culture at 1542 μg/ml (1.25 %) exceeded the normal range.  
The Panel noted that the additional scoring was conducted with an unjustified and non-homogeneous
approach; while for the solvent controls the additional 1000 cells derived from new blood cultures, for
the treated cells the additional scoring derived from the same blood cultures used in the first
experiment. Overall, differently from the authors, the Panel concluded that the results of the in vitro
micronucleus assay in the presence of S9-mix have to be considered as equivocal instead of negative
and therefore the test should be repeated (Lloyd, 2012).
Study results and comments on study validity are presented in Appendix C, Table 9.
5.2. Conclusions on Additional Genotoxicity Data in FGE.220Rev2
2,5-Dimethylfuran-3(2H)-one [FL-no: 13.119] did not induce mutations in the Ames test and did not
induce increased levels of micronuclei in an in vitro micronucleus assay with and without metabolic
activation. The Panel therefore concluded that [FL-no: 13.119] does not give rise to concern with
respect to genotoxicity and accordingly can be evaluated using the Procedure.
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] did not induce mutations in the Ames test with
and without metabolic activation and did not induce increased levels of micronuclei in an in vitro
micronucleus assay in the absence of S9-mix. However, the results of the micronucleus assay in the
presence of S9-mix were considered by the Panel to be equivocal. Therefore, the results of the in vitro
micronucleus assay should be clarified, e.g. by repetition of the study in the presence of S9-mix
applying the same conditions and possibly in addition modified conditions, or by a combined in vivo
micronucleus and comet assay, including analysis of liver. This is also applicable to 2,5-dimethyl-4-
methoxyfuran-3(2H)-one [FL-no: 13.089] and 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-no: 13.117]
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which are covered by the representative substance 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no:
13.175].
6. Additional Genotoxicity Data Evaluated by the Panel in FGE.220Rev3
6.1. In vitro Micronucleus Study for [FL-no: 13.175]
In response to the request to clarify the results of an in vitro micronucleus assay, the Industry has
submitted a new study with 4-acetyl-2,5-dimethylfuran-3(2H)-one: “Induction of micronuclei in
cultured human peripheral blood lymphocytes (Lloyd, 2014)”.
This study is a follow-up of the in vitro micronucleus study (Lloyd, 2012) evaluated in FGE.220Rev2.
In that study (Lloyd, 2012) the induction of micronuclei in human lymphocytes treated with [FL-no:
13.175] for 3+21 hours, in the presence of S9-mix, was considered by the Panel to be equivocal,
therefore a repetition of the experiment was requested.
The new study (Lloyd, 2014) was conducted to investigate the reproducibility of the findings under the
test conditions of 3+21 hours in the presence of S9-mix. In the follow-up study, the frequency of
micronuclei was assessed in cultured human peripheral blood lymphocytes (whole blood cultures
pooled from two healthy male volunteers in a single experiment) following treatment with the same
concentrations (1000, 1250 and 1542 μg/mL) of 4-acetyl-2,5-dimethylfuran-3(2H)-one as before in the
presence of a metabolising system (S9-mix) from livers of rats induced with Aroclor 1254. After 48
hours of culture initiation (stimulation by PHA), cultures were treated for 3 hours followed by 21
hours of recovery. The highest concentration was equal to the highest concentration used in the
previous study and is equivalent to 10 mM, or the maximum required test concentration (MW =
154.2). Cyclophosphamide (CPA 3.0 μg/mL) was used as a clastogenic positive control chemical in 
the presence of rat liver S9-mix. Cytochalasin B (6 μg/ml) was added at the end of the 3-hour 
treatment in order to block cytokinesis and generate binucleate cells for analysis, and it remained in
the cultures during the recovery period.
In this follow-up study, unlike the findings of the previously reported study, a marginally significant
increase (p ≤ 0.05) in the mean frequency of micronuclei was reported only at the lowest of the three
concentrations of 4-acetyl-2,5-dimethylfuran-3(2H)-one tested (1000 μg/mL) when compared to the 
concurrent vehicle control following scoring of 8000 cells (4000 cells per replicate). However, the
MNBN frequencies of both replicate cultures (0.68 % and 0.5 %) at this concentration remained well
within the normal historical control range (0.1 to 0.9 %). This finding shows that 4-acetyl-2,5-
dimethylfuran-3(2H)-one did not induce reproducible and consistent increases of micronuclei
frequency across replicate cultures in independent studies, indicating that the observed statistically
significant increases in MNBN in the first study (Lloyd, 2012) are of no biological relevance. On this
basis, 4-acetyl-2,5-dimethylfuran-3(2H)-one is considered negative for clastogenicity and aneugenicity
in the in vitro micronucleus assay when tested up to a maximum concentration of 1542 μg/mL for 
3 hours plus 21 hours recovery period in the presence of S9-mix.
Study results and comments on study validity are presented in Appendix C, Table 9.
6.2. Conclusions on Additional Genotoxicity Data in FGE.220Rev3
4-Acetyl-2,5-dimethylfuran-3(2H)-one [FL-no: 13.175] did not induce mutations in the Ames test with
and without metabolic activation (Bowen, 2011). There was an equivocal result observed in an in vitro
micronucleus assay, however, in the follow up study (Lloyd, 2014) 4-acetyl-2,5-dimethylfuran-3(2H)-
one did not induce reproducible statistically significant increase in MNBN cells across replicate
cultures indicating that the test substance can be considered negative for clastogenicity and
aneugenicity. The Panel therefore concluded that 4-acetyl-2,5-dimethylfuran-3(2H)-one [FL-no:
13.175] does not give rise to concern with respect to genotoxicity and accordingly can be evaluated
using the Procedure. These results are also applicable to two other substances in subgroup 4.4a: 2,5-
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dimethyl-4-methoxyfuran-3(2H)-one [FL-no: 13.089] and 2,5-dimethyl-4-ethoxyfuran-3(2H)-one [FL-
no: 13.117].
Based on the available data all 9 substances of this FGE are no longer of concern with respect to
genotoxicity and can be evaluated through the Procedure.
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Appendix A. Summary of Safety Evaluation Applying the Procedure
Table 3: Summary of Safety Evaluation Applying the Procedure
FL-no
JECFA-no
EU Register name Structural formula EU MSDI(a)
US MSDI
(µg/capita/day)
Class(b)
Evaluation procedure
path(c)
Outcome on the
named
compound(d), (e)
EFSA conclusion on the named
compound: (Procedure steps,
intake estimates, NOAEL,
genotoxicity)
Substances in subgroup 4.4a (Furan-3(2H)-ones)
13.089
1451
2,5-Dimethyl-4-methoxyfuran-3(2H)-
one
O
O O
0
0.7
Class II
A3: Intake below threshold
d Evaluated in FGE.220Rev3,
genotoxicity concern ruled out,
can be evaluated using the
Procedure.
13.119 2,5-Dimethylfuran-3(2H)-one O
O
1.9 Class III
B3: Intake below threshold,
B4: No adequate NOAEL
Additional data
required
Evaluated in FGE.220Rev2,
genotoxicity concern ruled out,
can be evaluated using the
Procedure.
13.117 2,5-Dimethyl-4-ethoxyfuran-3(2H)-one O
O O
0.018
No evaluation
Evaluated in FGE.220Rev3,
genotoxicity concern ruled out,
can be evaluated using the
Procedure.
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
1.3
No evaluation
Evaluated in FGE.220Rev3,
genotoxicity concern ruled out,
can be evaluated using the
Procedure.
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism)
13.010
1446
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one
O
OHO
0
5203
Class II
A3: Intake above threshold,
A4: Not endogenous,
A5: Adequate NOAEL exists
d Evaluated in FGE.220Rev1,
genotoxicity concern could be
ruled out. No safety concern at
the estimated level of intake
based on the MSDI approach.
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FL-no
JECFA-no
EU Register name Structural formula EU MSDI(a)
US MSDI
(µg/capita/day)
Class(b)
Evaluation procedure
path(c)
Outcome on the
named
compound(d), (e)
EFSA conclusion on the named
compound: (Procedure steps,
intake estimates, NOAEL,
genotoxicity)
13.084
1449
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone
O
OHO
0
13
Class II
A3: Intake below threshold
d Evaluated in FGE.220Rev1,
genotoxicity concern could be
ruled out. EFSA allocated the
substance to Class III. No safety
concern at the estimated level of
intake based on the MSDI
approach.
13.085
1450
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
0
0.07
Class II
A3: Intake below threshold
d Evaluated in FGE.220Rev1,
genotoxicity concern could be
ruled out. EFSA allocated the
substance to Class III. No safety
concern at the estimated level of
intake based on the MSDI
approach.
13.099
1456
4-Acetoxy-2,5-dimethylfuran-3(2H)-
one
O
OO
O
400
8
Class II
A3: Intake below threshold
d Evaluated in FGE.220Rev1,
genotoxicity concern could be
ruled out. EFSA allocated the
substance to Class III. No safety
concern at the estimated level of
intake based on the MSDI
approach.
13.176
1519
Furaneyl butyrate O
OO
O 4.2
4
Class III
No evaluation
Evaluated in FGE.220Rev1,
genotoxicity concern could be
ruled out. No safety concern at
the estimated level of intake
based on the MSDI approach.
(a): EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365) = µg/capita/day.
(b): Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day.
(c): Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot.
(d): No safety concern based on intake calculated by the MSDI approach of the named compound.
(e): Data must be available on the substance or closely related substances to perform a safety evaluation.
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Appendix B. QSAR Predictions on Mutagenicity
Table 4: QSAR Predictions on Mutagenicity in Five Models for 10 Ketones from Subgroup 4.4
FL-no
JECFA-no
EU Register name Structural formula (a) ISS Local Model
Ames Test
TA100 (b)
MultiCASE
Ames test (c)
MultiCASE
Mouse
lymphoma test (d)
MultiCASE
Chromosomal
aberration test in
CHO (e)
MultiCASE
Chromosomal
aberration test in
CHL (f)
Substances in subgroup 4.4a (Furan-3(2H)-ones)
13.089
1451
2,5-Dimethyl-4-methoxyfuran-3(2H)-
one
O
O O
OD* NEG OD* OD* OD*
13.117 2,5-Dimethyl-4-ethoxyfuran-3(2H)-one O
O
OD* NEG OD* OD* OD*
13.119 2,5-Dimethylfuran-3(2H)-one O
O O
OD* NEG OD* OD* OD*
13.157 5-Methylfuran-3(2H)-one O
O
OD* NEG POS OD* OD*
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
OD* NEG OD* OD* OD*
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the α,β-unsaturated double bond can be involved in keto-enol tautomerism) 
13.010
1446
4-Hydroxy-2,5-dimethylfuran-3(2H)-
one
O
OHO
OD* NEG NEG OD* NEG
13.084
1449
2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone
O
OHO
OD* NEG NEG OD* NEG
13.085
1450
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
OD* NEG NEG OD* NEG
13.099
1456
4-Acetoxy-2,5-dimethylfuran-3(2H)-
one
O
OO
O
OD* NEG OD* OD* OD*
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FL-no
JECFA-no
EU Register name Structural formula (a) ISS Local Model
Ames Test
TA100 (b)
MultiCASE
Ames test (c)
MultiCASE
Mouse
lymphoma test (d)
MultiCASE
Chromosomal
aberration test in
CHO (e)
MultiCASE
Chromosomal
aberration test in
CHL (f)
13.176 Furaneyl butyrate O
OO
O OD* NEG OD* OD* NEG
(a): Structure group 4.4: α,β-unsaturated ketones.
(b): Local model on aldehydes and ketones, Ames TA100. (NEG: Negative; POS: Positive; OD*: out of domain).
(c): MultiCase Ames test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal).
(d): MultiCase Mouse Lymphoma test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal).
(e): MultiCase Chromosomal aberration in CHO (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal).
(f): MultiCase Chromosomal aberration in CHL (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal).
* OD, out of applicability domain: not matching the range of conditions where a reliable prediction can be obtained in this model. These conditions may be physicochemical, structural,
biological etc.
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Appendix C. Summary of Carcinogenicity and Genotoxicity Studies
Table 5: Carcinogenicity Studies
Chemical Name [FL-no] Species; Sex
No/Sex/Group
Route Dose levels Duration Results Reference Comments
4-hydroxy-2,5-
dimethylfuran-3(2H)-one
[13.010]
Rats; Male, Female
60/sex/group
Diet 0, 100, 200 or
400 mg/kg
bw/day
2 years Males: No increase in tumour
incidences
Females: No increases in tumour
incidences
(Kelly and Bolte,
2003)
Valid (GLP/OECD
compliant)
The NOAEL was 200 mg/kg
bw/day based on reduced
mean body weight at the
highest dose.
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SUMMARY OF IN VITRO GENOTOXICITY DATA CONSIDERED BY THE PANEL IN FGE.220
Table 6: Summary of in vitro Genotoxicity Data Considered by the Panel in FGE.220
Chemical Name [FL-no] Test System Test Object Concentration Reported
Result
Reference Comments(e)
4-hydroxy-2,5-
dimethylfuran-3(2H)-one
[13.010]
Reversed
mutation
S. typhimurium TA1535,
TA1537, TA1538,TA100 and
TA98
10.0, 33.3, 100.0, 333.3,
1000, 2000, 3300, 4000,
6000 and 8000 µg/plate
Positive(a),(b) (Gilroy et al.,
1978)
Valid. Unpublished non-GLP study.
The report contains sufficient details.
Result is considered valid.
Reversed
mutation
S. typhimurium TA100 and
TA98
0 - 10000 µg/plate Positive(a),(b) (Hiramoto et al.,
1996b)
Valid. Positive in TA 100 (+/– S9);
negative in TA 98 (+/- S9).
Reversed
mutation
S. typhimurium TA100, TA102,
TA98 and TA97
500 - 4000 µg/plate Positive(a),(c) (Xing et al., 1988) Limited validity; No methodological
details, but stated to be performed
according to (Maron and Ames,
1983). Some errors reduce the
trustworthiness of the paper.
Reversed
mutation
E. coli WP2 uvrA- 10.0, 33.3, 100.0, 333.3,
1000 and 3300 µg/plate
Negative (Gilroy et al.,
1978)
Valid. Unpublished non-GLP study.
The report contains sufficient details.
Result is considered valid.
DNA damage B. subtilis H17 (Rec+) and M45
(Rec-)
20, 40, 60, 80 and 120
µg/disc
Positive (Xing et al., 1988) Validity cannot be evaluated (Test
system with low predictive value for
genotoxicity). No methodological
details, but stated to be performed
according to (Kada et al., 1972).
DNA strand
breaks
pBR322 DNA 2.6 - 780 µmol/l
(0.3 - 100 mg/l)
Positive (Hiramoto et al.,
1996b)
Valid. Single strand breaks caused by
redox cycling of the substance in
combination with metal ions,
generating reactive oxygen species.
4-Hydroxy-5-methylfuran-
3(2H)-one [13.085]
Reversed
mutation
S. typhimurium TA100 and
TA98
0 - 5000 µg/plate Positive(a),(b) (Hiramoto et al.,
1996a)
Limited validity. Limited due to
uncertainty of test substance. Positive
in TA 100 (+/– S9); negative in TA
98 (+/- S9).
DNA strand
breaks
pBR322 DNA 0 - 900 µmol/l
(0 - 103mg/l)
Positive(a),(d) (Hiramoto et al.,
1996a)
Valid. Single strand breaks caused by
redox cycling of the substance in
combination with metal ions,
generating reactive oxygen species.
2,5-Dimethyl-3(2H)-
Furanone [13.119]
Reverse
mutation
S. typhimurium TA1535,
TA1537, TA98,TA100 and
TA102,
0 - 5000 µg/plate Negative (RCC - CCR,
2007)
Valid. According to current
guidelines.
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2-ethyl-4-hydroxy-5-
methyl-3(2H)-furanone
[13.084]
Reversed
mutation
S. typhimurium TA100 and
TA98
0 – 10000 µg/plate Positive(a),(b) (Li et al., 1998) Valid. positive with and without S9
in TA 100; negative in TA98 (+/- S9).
DNA strand
breaks
pBR322 DNA 0 - 2000 µM Positive(d) (Li et al., 1998) Valid. Single strand breaks caused by
redox cycling of the substance in
combination with metal ions,
generating reactive oxygen species.
(a): With and without metabolic activation provided by S9 (9000 x g supernatant from rodent liver).
(b): Positive results only observed in TA100.
(c): Positive results in all strains at the highest dose tested.
(d): Only positive without inhibitors of redox cycling and ROS scavengers.
(e): Validity of genotoxicity studies:
• Valid.
• Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation).
• Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate test system).
• Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided).
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Table 7: Summary of in vivo Genotoxicity Data Considered by the Panel in FGE.220
Chemical Name [FL-no] Test System Test Object Route Dose
mg/kg bw
Reported
Result
Reference Comments(a)
4-hydroxy-2,5-
dimethylfuran-3(2H)-one
[13.010]
Micronucleus
formation
Mouse, bone
marrow
Not stated 0, 186, 232 or 309 Positive (Xing et al., 1988) Limited validity. Important
data not given; Reference to
methodological description
could not be traced.
Chromosomal
aberration
Mouse
spermatocytes
Not stated 0, 232, 464 or 928 Positive (Xing et al., 1988) Limited validity. Important
data not given; Reference to
methodological description
could not be traced.
Predominant aberration:
malsegregation of
chromosomes.
Sister chromatid
exchange
Mouse, bone
marrow
Intra-
abdominal
injection
0, 185, 232 and 303 Positive (Xing et al., 1988) Validity cannot be assessed.
Dose-related increase;
statistically significant at all
dose levels, but max increase
< 2-fold. Effect not
adequately specified; very
intense exposure to BrdU.
Non-validated protocol.
Relevance for the evaluation
of genotoxicity questionable.
Sister chromatid
exchange
Mouse
spermatocytes
Oral (gavage) 200, 400 or 800 Positive (Tian et al., 1992) Limited validity. Relevance
for the evaluation of
genotoxicity questionable;
non- validated test protocol.
Micronucleus
formation
Mouse early
sperm cells
Oral (gavage) 200, 400 or 800 Positive (Tian et al., 1992) Limited validity Non-
validated test protocol.
Micronucleus
formation
Mouse peripheral
blood cells
Gavage 1000, 2000 and 3000 Positive (Hiramoto et al.,
1998)
Valid
Micronucleus
formation
Male mice
peripheral
erythrocytes
i.p. 500, 1000 and 1500 Positive (Hiramoto et al.,
1996b)
Valid
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Table 7: Summary of in vivo Genotoxicity Data Considered by the Panel in FGE.220
Chemical Name [FL-no] Test System Test Object Route Dose
mg/kg bw
Reported
Result
Reference Comments(a)
2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [13.084]
Micronucleus
formation
Mouse peripheral
blood cells
Gavage 0, 1000, 2000 and 3000 positive (Hiramoto et al.,
1998)
Valid
Micronucleus
formation
Male mice
peripheral
erythrocytes
i.p. 0, 500 and 1000 positive (Li et al., 1998) Valid
(a): Validity of genotoxicity studies:
• Valid.
• Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation).
• Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate test system).
• Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided).
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SUMMARY OF ADDITIONAL GENOTOXICITY DATA CONSIDERED BY THE PANEL IN FGE.220REV1
Table 8: Summary of Additional Genotoxicity Data Considered by the Panel in FGE.220Rev1
Chemical Name [FL-no] Test System Test Object Route Dose Reported Result Reference Comments(a)
4-hydroxy-2,5-
dimethylfuran-3(2H)-one
[13.010]
Mouse Lymphoma L5178Ytk+/-
mouse lymphoma
cells
- 111, 167, 250, 375 and
750 µg/ml
Negative both with
and without S9
(Ross and Harris, 1979) Limited validity.
Study not performed
according to current
guideline. To short
treatment and no
differentiation
between small and
large colonies
Dominant lethal
assay in a rat
fertility study
Dominant lethals
in Crl:CD(SD)
male rats
(25/group)
Oral
gavage
100, 500 and 1000
mg/kg bw/day for 2
weeks(Phase I) and 9
weeks (Phase II)
no increase of
dominant lethal
effects
(Sloter, 2008) Valid GLP study in
accordance with ICH
Guideline 4.1.1.
(a): Validity of genotoxicity studies:
• Valid.
• Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation).
• Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate test system).
• Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided).
A study by Honarvar (Honarvar, 2008) was also submitted. However due to unknown identity of the tested material, this study is not included in the table.
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SUMMARY OF ADDITIONAL GENOTOXICITY DATA CONSIDERED BY THE PANEL IN FGE.220REV2 AND REV3
Table 9: Summary of Additional Genotoxicity Data Considered by the Panel in FGE.220Rev2 and Rev3
Chemical Name [FL-no] Test System Test Object Dose Reported
Result
Reference Comments
2,5-Dimethylfuran-
3(2H)-one [13.119]
Reverse
Mutation
S. typhimurium TA98, TA100,
TA102, TA1535 and TA1537
3 - 5000 μg/plate [1,2] Negative (Sokolowski,
2007)
All strains were negative. Study design
complied with current GLP and OECD
recommendations. Acceptable top
concentration was achieved.
S. typhimurium TA98, TA100,
TA102, TA1535 and TA1537
33 - 5000μg/plate [1,3] Negative
Micronucleus
Assay
Human peripheral blood
lymphocytes
900 - 1120 μg/mL [1,6] 
900 - 1120 μg/mL [4,7] 
Negative (Lloyd, 2011) The MNBN cell frequencies in all treated
cultures fell within the normal range.
Complies with draft OECD Guideline 487
and GLP recommendations.
4-Acetyl-2,5-
dimethylfuran-3(2H)-one
[13.175]
Reverse
Mutation
S. typhimurium TA98, TA100,
TA102, TA1535 and TA1537
0.32 – 5000 μg/plate [1,2] Negative (Bowen, 2011) Evidence of toxicity was observed at
5000μg/plate in all strains in the absence 
and presence of S-9. Study design
complied with current GLP and OECD
recommendations.
78.13 - 5000 μg/plate [2,4] 
78.13 - 5000μg/plate [3,5] 
Negative
Micronucleus
Assay
Human peripheral blood
lymphocytes
1000 - 1542 μg/mL [1,6]  
400 - 900 μg/mL [4,7] 
Equivocal (Lloyd, 2012) Study in compliance with GLP and
OECD recommendations. Statistical
significant increase, dose-related, in the
presence of S9-mix at all three
concentrations in a first experiment.
Lower statistical significance at the two
highest concentrations in an enlarged
scoring, carried out with an unjustified
approach. Mean MNBN cell frequencies
fell within the historical control range
with exception of a single replicate (see
main text).
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Table 9: Summary of Additional Genotoxicity Data Considered by the Panel in FGE.220Rev2 and Rev3
Chemical Name [FL-no] Test System Test Object Dose Reported
Result
Reference Comments
1000, 1250 and 1542 μg/mL 
[5,6]
Negative (Lloyd, 2014) Follow up study in compliance with GLP
and OECD recommendations.
Statistically significant increase (p ≤ 
0.05) in the mean frequency of
micronuclei was reported only at the
lowest of the three concentrations tested
(1000 μg/mL) but remained well within 
the normal historical control range values
(0.1 to 0.9 %) for both replicate cultures.
[1] With and without S9 metabolic activation.
[2] Plate incorporation method.
[3] Pre-incubation method.
[4] Without S9 metabolic activation.
[5] With S9 metabolic activation.
[6] 3-hour incubation with 21-hour recovery period.
[7] 24-hour incubation with no recovery period.
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ABBREVIATIONS
CA Chromosomal aberration
CAS Chemical Abstract Service
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
CoE Council of Europe
CPA Cyclophosphamide
DNA Deoxyribonucleic acid
EFFA European Flavour Association
EFSA European Food Safety Authority
EU European Union
FGE Flavouring Group Evaluation
FLAVIS (FL) Flavour Information System (database)
GLP Good Laboratory Practice
ID Identity
IR Infrared spectroscopy
JECFA The Joint FAO/WHO Expert Committee on Food Additives
MN Micronuclei
MNBN MicroNucleated BiNucleate cells
MS Mass spectra
MSDI Maximised Survey-derived Daily Intake
MW Molecular Weight
NMR Nuclear Magnetic Resonance
No Number
OECD Organisation for Economic Co-operation and Development
(Q)SAR (Quantitative) Structure Activity Relationship
PHA Phytohaemagglutinin
SCE Sister chromatid exchange
SCF Scientific Committee on Food
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WHO World Health Organization
